Machine-vision Image Guidance System Receives HSA Approval in Singapore Reports 7D Surgical

Achieves First Unit Sale in Southeast Asia

Machine-vision Image Guidance System (MvIGS) for spinal navigation by  7D Surgical has received approval from the Health Sciences Authority (HSA) in Singapore. The news was announced today,

In addition, 7D Surgical has already completed its first system sale through its distribution partnership with Transmedic, a premier medical technology, sales, and distribution company serving hospitals, clinics, and health centers in Southeast Asia.

“We are incredibly thrilled to bring our 7D technology to market in Singapore,” said Beau Standish, Chief Executive Officer of 7D Surgical. “We have already delivered this novel technology to the USA, Canada, Australia, New Zealand, and the Caribbean and are now excited to offer our innovations in the Asian market. Our machine vision surgical innovations improve patient outcomes by reducing surgical risk, improve implant accuracy, increase surgical efficiencies, while eliminating navigation-based intraoperative radiation. Expansion into Asia has been a strategic priority to share our innovations with the global healthcare community.”

The 7D Surgical Machine-vision Image Guidance System is the only approved image guidance system that utilizes a novel and proprietary camera-based technology, coupled with machine-vision algorithms to eliminate the long-standing frustrations with legacy surgical navigational platforms. The speed, accuracy, and efficiency of the MvIGS System, combined with a fundamentally streamlined surgical workflow provides significant economic value and harnesses the true potential of image guidance – all while enabling a safe, radiation-free surgical environment.

Associate Professor Kevin Lim, Chairman of Orthopaedic Surgery at KK Women’s and Children’s Hospital in Singapore, stated, “As a paediatric spine surgeon, the 7D system allows me to safely and accurately navigate pedicle screws at any level for any type of case, without disruption to my workflow. It is particularly paramount in some of my more complex cases, and I am proud to be able to offer my patients the very latest in spine surgery while eliminating unnecessary radiation in the operating room.”

“We are very pleased to be partnered with 7D Surgical and representing the technology in Singapore and eventually all of Southeast Asia,” said Mr. Teo Kee Meng, Managing Director at Transmedic. “We are excited by 7D Surgical’s strong innovation pipeline and believe in their cost-effective, fast, and radiation-free solution for spinal image guidance to the hospitals, clinicians, and patients that we support.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.